Biotech Company Glafabra Therapeutics Collaborates with University of Utah for Fabry Disease Clinical Investigation
January 11, 2025 — Glafabra Therapeutics partners with University of Utah for groundbreaking Fabry disease clinical investigation. Collaboration aims to advance development of new treatment for rare genetic disorder, addressing unmet medical need.